An Arm and a Leg: The Medicare episode

The FDA approved a once-daily oral combination of vanzacaftor/tezacaftor/deutivacaftor (Alyftrek) for cystic fibrosis (CF) in adults and children 6 years and up, drugmaker Vertex Pharmaceuticals

A start­up that helps com­mu­ni­ty work­ers guide Med­ic­aid mem­bers to the care they need just raised a new round of fund­ing. Peo­ple on gov­ern­ment-run Med­ic­aid

Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index (BMI) in the years before diagnosis,